University of Iowa   

Questions discussed in this category



Being that this is a favorable histology would you use Oncotype Dx to help decide on neoadjuvant chemotherapy? Would you recommend neoadjuvant endocri...

Knowing that benefit of contralateral mastectomy is lower in older women who has already manifested BRCA related cancer and 10-20 % mastectomy related...

Given that DBA is associated with increased incidence of MDS, AML and other solid tumors, would this modify your treatment recommendations?

In a patient with who had undergone neoadjuvant TCH-P, lumpectomy, and RT and is currently on AI, pertuzumab, and trastuzumab, how do you think about ...


Papers discussed in this category


The New England journal of medicine, 2019-02-14

N. Engl. J. Med.,

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2017-08-10

PLoS ONE, 2018 May 16

N Engl J Med, 2011 Oct 6

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2019-08-01

N Engl J Med, 2015 Jan 8

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013-07-01

Lancet Oncol., 2015-03-01

Ann. Surg. Oncol., 2013 Nov 23

Breast cancer research and treatment, 2017-08

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2012-07-20